A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

Condition:   Triple Negative Breast Neoplasms Interventions:   Drug: Atezolizumab;   Drug: Placebo;   Drug: Gemcitabine;   Drug: Capecitabine;   Drug: Carboplatin Sponsor:   Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials